We read with interest the letter and study synopsis from Ivanisevic and Djelmis (1) and published descriptions (n = ∼30) of their cohort of pregnant women with type 1 diabetes (T1D) (2). It is unclear how many of their participants had detectable C-peptide at baseline. Typically, <50% of women with T1D have detectable C-peptide in early pregnancy, suggesting residual β-cell function (3).
…. more: Diabetes Journals (ADA) (Quelle/Source)
